MedAustron Ion Therapy Centre, Wiener Neustadt, Austria.
Proton Therapy Centre Czech, Medical Physics, Prague, Czechia.
Acta Oncol. 2019 Dec;58(12):1720-1730. doi: 10.1080/0284186X.2019.1648858. Epub 2019 Aug 8.
A collaborative network between proton therapy (PT) centres in Trento in Italy, Poland, Austria, Czech Republic and Sweden (IPACS) was founded to implement trials and harmonize PT. This is the first report of IPACS with the aim to show the level of harmonization that can be achieved for proton therapy planning of head and neck (sino-nasal) cancer. CT-data sets of five patients were included. During several face-to-face and online meetings, a common treatment planning protocol was developed. Each centre used its own treatment planning system (TPS) and planning approach with some restrictions specified in the treatment planning protocol. In addition, volumetric modulated arc therapy (VMAT) photon plans were created. For CTV1, the average D was 59.3 ± 2.4 Gy(RBE) for protons and 58.8 ± 2.0 Gy(RBE) for VMAT (aim was 56 Gy(RBE)). For CTV2, the average D was 71.2 ± 1.0 Gy(RBE) for protons and 70.6 ± 0.4 Gy(RBE) for VMAT (aim was 70 Gy(RBE)). The average D for the spinal cord was 25.1 ± 8.5 Gy(RBE) for protons and 47.6 ± 1.4 Gy(RBE) for VMAT. The average D for chiasm was 46.5 ± 4.4 Gy(RBE) for protons and 50.8 ± 1.4 Gy(RBE) for VMAT, respectively. Robust evaluation was performed and showed the least robust plans for plans with a low number of beams. In conclusion, several influences on harmonization were identified: adherence/interpretation to/of the protocol, available technology, experience in treatment planning and use of different beam arrangements. In future, all OARs that should be included in the optimization need to be specified in order to further harmonize treatment planning.
一个由意大利特伦托、波兰、奥地利、捷克共和国和瑞典的质子治疗(PT)中心组成的协作网络成立,旨在实施试验并协调 PT。这是 IPACS 的第一份报告,旨在展示可以实现的头颈部(鼻旁窦)癌症质子治疗计划的协调水平。纳入了五名患者的 CT 数据集。在多次面对面和在线会议中,制定了共同的治疗计划协议。每个中心都使用自己的治疗计划系统(TPS)和计划方法,并在治疗计划协议中规定了一些限制。此外,还创建了容积调强弧形治疗(VMAT)光子计划。对于 CTV1,质子的平均 D 为 59.3 ± 2.4 Gy(RBE),VMAT 为 58.8 ± 2.0 Gy(RBE)(目标为 56 Gy(RBE))。对于 CTV2,质子的平均 D 为 71.2 ± 1.0 Gy(RBE),VMAT 为 70.6 ± 0.4 Gy(RBE)(目标为 70 Gy(RBE))。脊髓的平均 D 为质子 25.1 ± 8.5 Gy(RBE),VMAT 为 47.6 ± 1.4 Gy(RBE)。对于视交叉,质子的平均 D 为 46.5 ± 4.4 Gy(RBE),VMAT 为 50.8 ± 1.4 Gy(RBE)。进行了稳健性评估,结果表明,光束数量较少的计划稳健性最低。总之,确定了对协调的几个影响因素:协议的遵守/解释/解释、可用技术、治疗计划经验以及不同光束排列的使用。在未来,需要指定应包含在优化中的所有 OAR,以进一步协调治疗计划。